| 000 | 01728 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513214135.0 | ||
| 264 | 0 | _c20000801 | |
| 008 | 200008s 0 0 eng d | ||
| 022 | _a0735-1097 | ||
| 024 | 7 |
_a10.1016/s0735-1097(00)00721-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKapadia, S R | |
| 245 | 0 | 0 |
_aElevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload. _h[electronic resource] |
| 260 |
_bJournal of the American College of Cardiology _cJul 2000 |
||
| 300 |
_a208-12 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntigens, CD _xblood |
| 650 | 0 | 4 |
_aAortic Valve Stenosis _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aEchocardiography, Doppler |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Ventricles _xdiagnostic imaging |
| 650 | 0 | 4 |
_aHemodynamics _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitral Valve Insufficiency _xblood |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xblood |
| 650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor, Type I |
| 650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor, Type II |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 700 | 1 | _aYakoob, K | |
| 700 | 1 | _aNader, S | |
| 700 | 1 | _aThomas, J D | |
| 700 | 1 | _aMann, D L | |
| 700 | 1 | _aGriffin, B P | |
| 773 | 0 |
_tJournal of the American College of Cardiology _gvol. 36 _gno. 1 _gp. 208-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0735-1097(00)00721-x _zAvailable from publisher's website |
| 999 |
_c10848807 _d10848807 |
||